- Featured Product
- KD/KO Validated
Alpha Galactosidase A Monoklonaler Antikörper
Alpha Galactosidase A Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2B2C5
Kat-Nr. : 66121-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66121-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA Alpha Galactosidase A und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG2a |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | Alpha Galactosidase A fusion protein Ag7505 |
Vollständiger Name | galactosidase, alpha |
Berechnetes Molekulargewicht | 49 kDa |
Beobachtetes Molekulargewicht | 49 kDa |
GenBank-Zugangsnummer | BC002689 |
Gene symbol | GLA |
Gene ID (NCBI) | 2717 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
GLA, also named as Melibiase and Alpha-galactosidase A, belongs to the glycosyl hydrolase 27 family. It hydrolyzes terminal, non-reducing alpha-D-galactose residues in alpha-D-galactosides, including galactose oligosaccharides, galactomannans and galactolipids. Fabry disease is an X-linked lysosomal storage disorder resulting from the deficient activity of GLA. Enzyme replacement therapy (ERT) with GLA is currently the most effective therapeutic strategy for patients with Fabry disease, a lysosomal storage disease.